Jung-Hoon Park

Dr. Jung-Hoon Park

Biomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Biomaterials
Verified
Journal Article
Closed access
KKKwang-Soo Kim
Kwang-Soo Kim
JHJun-Hyeok Han
Jun-Hyeok Han
Jung-Hoon ParkJung-Hoon Park
Jung-Hoon Park
HKHyung-Keun Kim
Hyung-Keun Kim
SCSeung Hee Choi
Seung Hee Choi
Kyung-soon ParkKyung-soon Park
Kyung-soon Park

1 May 2012 in American Journal of Roentgenology
Verified
Journal Article
Closed access
JPJu Yang Park
Ju Yang Park
HSHo-Young Song
Ho-Young Song
JKJin Hyoung Kim
Jin Hyoung Kim
Jung-Hoon ParkJung-Hoon Park
Jung-Hoon Park
HNHan Kyu Na
Han Kyu Na
SPSeung-Il Park
Seung-Il Park
OBJECTIVE. The purpose of this article is to retrospectively evaluate the long-term clinical results of balloon dilation in the treatment of benign anastomotic strictures after esophagectomy and to identify factors associated with stricture recurrence. MATERIALS AND METHODS. From January 1996 to June 2011, a total of 309 sessions of balloon dilation were performed in 155 patients with benign anastomotic strictures after esophagectomy. Long-term clinical effectiveness was assessed using the following variables: technical and clinical success, complications, and patency rates. Factors independently related to recurrence were evaluated with the Cox model. Tested variables were age, sex, operation type, postoperative anastomotic leakage, balloon size, length of stricture, time to postoperative stricture development, complications, and neoadjuvant chemoradiotherapy. RESULTS. The mean follow-up period was 37 months (range, 1–159 months). Overall clinical success was achieved in 153 patients (99%) after a single...

1 January 2017 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
KKKun Yung Kim
Kun Yung Kim
JTJiaywei Tsauo
Jiaywei Tsauo
HSHo-Young Song
Ho-Young Song
PKPyeong Hwa Kim
Pyeong Hwa Kim
Jung-Hoon ParkJung-Hoon Park
Jung-Hoon Park
Kim KY, et al. J Korean Med Sci. 2017 Jul;32(7):1062-1071. https://doi.org/10.3346/jkms.2017.32.7.1062


27 September 2012 in European Radiology
Verified
Journal Article
Closed access
PDF file
HNHan Kyu Na
Han Kyu Na
HSHo-Young Song
Ho-Young Song
JKJin Hyoung Kim
Jin Hyoung Kim
Jung-Hoon ParkJung-Hoon Park
Jung-Hoon Park
MKMin Kyoung Kang
Min Kyoung Kang
SOSe Jin Oh
Se Jin Oh

1 July 2024 in Bioactive Materials
Verified
Journal Article
Open access
HLHyun Lee
Hyun Lee
DWDong-Sung Won
Dong-Sung Won
SPSinwoo Park
Sinwoo Park
YPYubeen Park
Yubeen Park
JKJi Won Kim
Ji Won Kim
Hyun-Do JungHyun-Do Jung
Hyun-Do Jung
Biliary strictures are characterized by the narrowing of the bile duct lumen, usually caused by surgical biliary injury, cancer, inflammation, and scarring from gallstones. Endoscopic stent placement is a well-established method for the management of biliary strictures. However, maintaining optimal mechanical properties of stents and designing surfaces that can prevent stent-induced tissue hyperplasia and biofilm formation are challenges in the fabrication of biodegradable biliary stents (BBSs) for customized treatment. This study proposes a novel approach to fabricating functionalized polymer BBSs with nanoengineered surfaces using 3D printing. The 3D printed stents, fabricated from bioactive silica poly(ε-carprolactone) (PCL) via a sol–gel method, exhibited tunable mechanical properties suitable for supporting the bile duct while ensuring biocompatibility. Furthermore, a nanoengineered surface layer was successfully created on a sirolimus (SRL)-coated functionalized PCL (fPCL) stent using Zn ion sputtering-based plasma immersion ion implantation (S-PIII) treatment to enhance the performance of the stent. The nanoengineered surface of the SRL-coated fPCL stent effectively reduced bacterial responses and remarkably inhibited fibroblast proliferation and initial burst release of SRL in vitro systems. The physicochemical properties and biological behaviors, including in vitro biocompatibility and in vivo therapeutic efficacy in the rabbit bile duct, of the Zn-SRL@fPCL stent demonstrated its potential as a versatile platform for clinical applications in bile duct tissue engineering.